The Global Fund has become more prescriptive about what should be included in submissions for funding for the next phase of a grant. While this trend began under the Grant Renewals Panel, the formation of the Grant Approvals Committee (GAC) in the second quarter of 2013 brought with it a noticeable upswing.
Read about the Global Fund’s decision in December 2013 to approve funding for some interim applicants and to renew funding for some grants:
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has approved continued funding of up to $253.8 million for 13 applicants in a decision announced on 23 December.
The Board of the Global Fund to Fights AIDS, Tuberculosis and Malaria has approved continued funding of up to $46.4 million for three applicants. The Board decision was announced on 26 November.
The Board’s approval followed recommendations from the Technical Review Panel (TRP) and the Secretariat, including the Grant Approvals Committee (GAC). See the table for a full breakdown.
When the Global Fund Board approved early applicant funding for Myanmar for all three diseases (see first article in this newsletter), it also approved funding for the renewal of existing grants for these diseases. The total funding approved for Myanmar is shown in the following table:
When the Global Fund Board approved early applicant funding for El Salvador for HIV under the new funding model (NFM), it also approved funding for the renewal of two existing HIV grants. The amount of renewal funding approved was $3.9 million. When combined with the $20.2 million in NFM indicative funding and the $2.9 million in NFM incentive funding, total funding awarded to El Salvador was $27.0 million.
The Global Fund says that over the past few months, it has taken steps to improve the outcomes of the grant renewal process. This information is contained in a report prepared by General Manager Gabriel Jaramillo for the Board meeting in Geneva.
The Global Fund has posted on its website information on changes to the grant renewals process as a result of decisions made at the November 2011 meeting of the Board. The information is available here.
The Global Fund Board has formed a working group to examine options for changes to the application, renewal and approval processes for new and existing investments.
In August 2010, the Global Fund Board rejected a request for funding for Phase 2 of a Round 6 tuberculosis (TB) grant in Sri Lanka. This is the first time in more than three years that the Global Fund has declined to approve a Phase 2 request. Some Board members opposed the decision.